Work

Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form

Year: 2016

Type: article

Source: Organic Process Research & Development

DOI: 10.1021/acs.oprd.5b00369

Authors: Andrew S. Wells, John W. Wong, Peter C. Michels, David A. Entwistle, Keith Fandrick, Gregory L. Finch, Animesh Goswami, Heewon Lee, Stefan Mix, Thomas S. Moody, Long Pang, Robert K. Sato, Nicholas J. Turner, Timothy J. Watson

Institutions: Quorn (United Kingdom), Albany Molecular Research (United States), Codexis (United States), Boehringer Ingelheim (United States), Bristol-Myers Squibb (United States), Almac (United Kingdom), University of Manchester, Pfizer (United States)

Language: English

Topic: Enzyme Catalysis and Immobilization

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: European Federation of Pharmaceutical Industries and Associations, Seventh Framework Programme

Award: G7685031107

OpenAlex ID: W2276491111

FWCI: 1.123

Cites: 24

Cited by: 25

Related to: 10